切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2024, Vol. 19 ›› Issue (01) : 46 -50. doi: 10.3877/cma.j.issn.1673-9450.2024.01.009

论著

脱细胞同种异体真皮联合自体皮修复糖尿病足创面的临床效果
廖晓霜, 曾李(), 杨波()   
  1. 402760 重庆医科大学附属璧山医院创面修复与烧伤科
  • 收稿日期:2023-11-19 出版日期:2024-02-01
  • 通信作者: 曾李, 杨波

Clinical effect of acellular allograft dermis combined with autologous skin in repairing diabetic foot wound

Xiaoshuang Liao, Li Zeng(), Bo Yang()   

  1. Department of Wound Repair and Burns, Bishan Hospital of Chongqing Medical University, Chongqing 402760, China
  • Received:2023-11-19 Published:2024-02-01
  • Corresponding author: Li Zeng, Bo Yang
引用本文:

廖晓霜, 曾李, 杨波. 脱细胞同种异体真皮联合自体皮修复糖尿病足创面的临床效果[J]. 中华损伤与修复杂志(电子版), 2024, 19(01): 46-50.

Xiaoshuang Liao, Li Zeng, Bo Yang. Clinical effect of acellular allograft dermis combined with autologous skin in repairing diabetic foot wound[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(01): 46-50.

目的

探讨脱细胞同种异体真皮(HADM)联合自体皮复合移植修复糖尿病足创面的临床效果。

方法

收集2020年12月至2022年7月,重庆医科大学附属璧山医院创面修复与烧伤科收治的7例Wager 4级糖尿病足患者资料,其中男4例,女3例;年龄68~82岁(平均74.5岁),创面面积12 cm×7 cm~16 cm×12cm。病程6个月~2年,平均13个月。所有病例均行HADM联合自体皮复合移植修复创面。分别于术后7~10 d观察植皮区皮片色泽、存活面积,统计植皮成活率、再手术率、不良反应,评估患者创面愈合情况。

结果

7例患者随访时间1个月~ 2年(平均7个月)。平均愈合时间为9 d,再手术率为0,皮片存活率为95%~100%,植皮区未见明显色沉及萎缩。术后植皮区均成活,无再手术病例,无不良反应,患者均治愈、未复发。

结论

针对糖尿病足的大面积皮肤软组织破溃,应用HADM联合自体皮复合移植修复,其手术操作简便,术后植皮区成活率高,无复发,修复效果良好。

Objective

To investigate the clinical efficacy of combining human acellular demal mantrix (HADM) with autologous skin transplantation in repairing of diabetic foot wounds.

Methods

The data of seven patients with Wagre grade 4 diabetic foot, who were admitted to the Department of Wound Repair and Burns, Bishan Hospital Affiliated to Chongqing Medical University from December 2020 to July 2022, were collected. The patient cohort consisted of four males and three females, aged between 68 and 82 years (average age 74.5 years), with wound areas ranging from 12 cm ×7 cm to 16 cm×12 cm. The duration of the disease varied from 6 months to 2 years, with an average duration of 13 months. All cases underwent HADM combined with autologous skin transplantation for repair purposes. Skin color and survival area of the graft were assessed between 7 and 10 days post-operation, while the survival rate, reoperation rate, and adverse reactions associated with the skin graft were recorded.

Results

The follow-up period for 7 patients ranged from 1 month to 2 years, with a mean duration of 7 months. The average healing time was 9 days, with a reoperation rate of 0. All skin grafts exhibited complete survival without any cases requiring reoperation or adverse reactions, resulting in successful cure and no recurrence. The skin grafts demonstrated a high survival rate ranging from 95% to 100%, and there were no noticeable pigmentation or atrophy observed in the grafted area.

Conclusion

For the large area of skin and soft tissue rupture of diabetic foot, the application of HADM combined with autologous skin composite transplantation has simple operation, high survival rate of postoperative skin graft area, no recurrence, and good repair effect.

图1 典型病例1。患者男,68岁。因右足溃烂2周就诊。A、B示术前右足创面;C示植皮前15 cm×10 cm缺损创面;D示术后即刻;E示术后1月随访情况;F示术后18个月随访情况
图2 典型病例2。患者男,81岁,因右足溃烂2个月就诊。A、B示术前右足创面;C示植皮前13 cm×8 cm缺损创面;D示术后即刻;E示术后1个月随访情况;F示术后3个月随访情况
[1]
中国医疗保健国际交流促进会糖尿病足病分会,国际血管联盟中国分部糖尿病足病专家委员会. 中国糖尿病足诊治指南[J]. 中国临床医生杂志2020, 48(1): 19-27.
[2]
Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis[J]. Ann Med, 2017, 49(2): 106-116.
[3]
Sen P, Demirdal T, Emir B. Meta-analysis of risk factors for amputation in diabetic foot infections[J]. Diabetes Metab Res Rev, 2019, 35(7): e3165.
[4]
Chen L, Sun S, Gao Y, et al. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies[J]. Diabetes Obes Metab, 2023, 25(1): 36-45.
[5]
王江宁,高磊. 糖尿病足慢性创面治疗的新进展[J]. 中国修复重建外科杂志2018, 32(7): 832-837.
[6]
中国微循环学会周围血管疾病专业委员会糖尿病足学组. 糖尿病足创面修复治疗专家共识[J]. 中华糖尿病杂志2018, 10(5): 305-309.
[7]
王晓军,郝凤杰. 不同Wagner分级糖尿病足患者的临床及治疗特点[J]. 临床与病理杂志2018, 38(11): 2383-2388.
[8]
Luthringer M, Mukherjee T, Arguello-Angarita M, et al. Human-derived acellular dermal matrix grafts for treatment of diabetic foot ulcers: a systematic review and meta-analysis[J]. Wounds, 2020, 32(2): 57-65.
[9]
高磊,秦新愿,李天博,等. 脱细胞同种异体真皮与自体刃厚皮联合移植修复糖尿病足创面[J]. 中国组织工程研究2022, 26(14): 2138-2143.
[10]
薛春利,胡志成,杨祖贤,等. 异体脱细胞真皮基质治疗糖尿病足溃疡临床效果荟萃分析[J]. 中华烧伤杂志2016, 32(12): 725-729.
[11]
郭海雷,凌翔伟,刘政军,等. 刃厚头皮与异体脱细胞真皮基质复合移植修复特大面积烧伤患者手部深度创面[J]. 中华烧伤杂志2019, 35(12): 876-878.
[12]
Sharma H, Sharma S, Krishnan A, et al. The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: systematic review and meta-analysis[J]. PLoS One, 2022, 17(4): e0267412.
[13]
Chen L, Zhang S, Da J, et al. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer[J]. Ann Palliat Med, 2021, 10(10): 10830-10839.
[14]
王新刚,张惟,余朝恒,等. 脱细胞真皮基质联合负压治疗修复深度皮肤缺损的临床疗效观察[J]. 中华急诊医学杂志2022, 31(6): 828-830.
[15]
Sen P, Demirdal T, Emir B. Meta-analysis of risk factors for amputation in diabetic foot infections[J]. Diabetes Metab Res Rev, 2019, 35(7): e3165.
[16]
Wukich DK, Hobizal KB, Sambenedetto TL, et al. Outcomes of osteomyelitis in patients hospitalized with diabetic foot infections[J]. Foot Ankle Int, 2016, 37(12): 1285-1291.
[17]
Lin X, Wu Y, Huang H, et al. Antibiotic-loaded bone substitutes therapy in the management of the moderate to severe diabetic foot infection: a meta-analysis[J]. Wound Repair Regen, 2023, 31(2): 205-226.
[18]
Chen L, Sun S, Gao Y, et al. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies[J]. Diabetes Obes Metab, 2023, 25(1): 36-45.
[19]
Carro GV, Saurral R, Witman EL, et al. Ataque de pie diabético. Descripción fisiopatológica, presentación clínica, tratamiento y evolución [Diabetic foot attack. Pathophysiological description, clinical presentation, treatment and outcomes][J]. Medicina (B Aires), 2020, 80(5): 523-530.
[20]
Wang Y, Chao N, Yin D. A net meta-analysis of the effectiveness of different types of dressings in the treatment of diabetic foot[J]. Comput Math Methods Med, 2022, 2022: 4915402.
[21]
Huang C, Wang R, Yan Z. Silver dressing in the treatment of diabetic foot: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(7): e24876.
[22]
薛春利. 脱细胞真皮基质在创伤修复与组织重建中临床应用的系统评价[D]. 暨南大学,2016.
[1] 孙艺玮, 陈炜, 秦巍, 杜景辰, 孟昕, 周永军. 血管腔内介入治疗糖尿病足合并下肢动脉硬化闭塞症患者术后再狭窄与血清炎症因子的相关性[J]. 中华损伤与修复杂志(电子版), 2024, 19(01): 34-40.
[2] 张健, 刘小龙, 查天建, 姚俊杰, 王傑. 富含血小板血浆联合异种脱细胞真皮基质修复糖尿病足缺血性创面的临床效果[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 503-506.
[3] 赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[4] 鲍亚慧, 曹志斌, 王健楠, 别瑶, 孙晓东, 惠宗光. 应用羧甲基纤维素钠银敷料联合封闭负压吸引治疗糖尿病足溃疡的疗效[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 326-330.
[5] 刘江涛, 王一勇, 欧阳容兰, 黄书润. 采用改良胸脐带蒂皮瓣修复手腕背部深度创面的临床效果[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 321-325.
[6] 黄跃生. 努力建设高水平创面修复新学科[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 185-187.
[7] 陆树良. 重视创面修复学科的规范化建设和理论培训[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 188-190.
[8] 杨润功. 重视国家军队重大医疗需求以推动创面修复科快速发展[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 191-196.
[9] 王雪, 程微, 苏建东. 微针法表皮移植应用的新进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 270-273.
[10] 雷霞, 李炳辉, 王晓蓉, 张丽娟, 刘慧真, 王卉, 李恭驰. 对糖尿病足溃疡诱因与发生部位的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 104-108.
[11] 余静雅, 戴燕, 石玉兰, 向利娟, 吴淑君. 对门诊糖尿病足患者治疗费用的分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 128-133.
[12] 李晓光, 周杰玉, 刘凯, 火子榕, 谭皓月, 何悦, 张治华, 王振涛, 汪照炎. 拉杆式皮肤扩展器在股前外侧皮瓣术后缺损中的应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 144-147.
[13] 魏忠玲, 陈赟, 叶美霞, 杨珺雯, 袁竺方. 不同种类敷料治疗糖尿病足疗效比较的网状荟萃分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 157-165.
[14] 肖仕初. 微型皮移植的创新与应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 184-184.
[15] 李芳, 李全, 曹胜军, 王凌峰. 生长因子和细胞因子在创面修复过程中作用的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 174-179.
阅读次数
全文


摘要